CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Notoginsenoside Ft1 Promotes Fibroblast Proliferation via PI3K/Akt/mTOR Signaling Pathway and Benefits Wound Healing in Genetically Diabetic Mice
Zhang, Eryun1,3; Gao, Bo1,3; Yang, Li1,3; Wu, Xiaojun1,2; Wang, Zhengtao1,2
刊名The Journal of pharmacology and experimental therapeutics
2016-02
卷号356期号:2页码:324-32
ISSN号1521-0103
DOI10.1124/jpet.115.229369
文献子类Article
英文摘要Wound healing requires the essential participation of fibroblasts, which is impaired in diabetic foot ulcers (DFU). Notoginsenoside Ft1 (Ft1), a saponin from Panax notoginseng, can enhance platelet aggregation by activating signaling network mediated through P2Y12 and induce proliferation, migration, and tube formation in cultured human umbilical vein endothelial cells. However, whether it can accelerate fibroblast proliferation and benefit wound healing, especially DFU, has not been elucidated. In the present study on human dermal fibroblast HDF-a, Ft1 increased cell proliferation and collagen production via PI3K/Akt/mTOR signaling pathway. On the excisional wound splinting model established on db/db diabetic mouse, topical application of Ft1 significantly shortened the wound closure time by 5.1 days in contrast with phosphate-buffered saline (PBS) treatment (15.8 versus 20.9 days). Meanwhile, Ft1 increased the rate of re-epithelialization and the amount of granulation tissue at day 7 and day 14. The molecule also enhanced mRNA expressions of COL1A1, COL3A1, transforming growth factor (TGF)-β1 and TGF-β3 and fibronectin, the genes that contributed to collagen expression, fibroblast proliferation, and consequent scar formation. Moreover, Ft1 facilitated the neovascularization accompanied with elevated vascular endothelial growth factor, platelet-derived growth factor, and fibroblast growth factor at either mRNA or protein levels and alleviated the inflammation of infiltrated monocytes indicated by reduced tumor necrosis factor-α and interleukin-6 mRNA expressions in the diabetic wounds. Altogether, these results indicated that Ft1 might accelerate diabetic wound healing by orchestrating multiple processes, including promoting fibroblast proliferation, enhancing angiogenesis, and attenuating inflammatory response, which provided a great potential application of it in clinics for patients with DFU.
语种英语
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/266466]  
专题中国科学院上海药物研究所
通讯作者Wu, Xiaojun; Wang, Zhengtao
作者单位1.Department of Pharmacognosy, China Pharmaceutical University, Nanjing, China (E.Z, Z.W.);
2.and Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China (B.G., L.Y., X.W., Z.W.)
3.and Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China (B.G., L.Y., X.W., Z.W.);
推荐引用方式
GB/T 7714
Zhang, Eryun,Gao, Bo,Yang, Li,et al. Notoginsenoside Ft1 Promotes Fibroblast Proliferation via PI3K/Akt/mTOR Signaling Pathway and Benefits Wound Healing in Genetically Diabetic Mice[J]. The Journal of pharmacology and experimental therapeutics,2016,356(2):324-32.
APA Zhang, Eryun,Gao, Bo,Yang, Li,Wu, Xiaojun,&Wang, Zhengtao.(2016).Notoginsenoside Ft1 Promotes Fibroblast Proliferation via PI3K/Akt/mTOR Signaling Pathway and Benefits Wound Healing in Genetically Diabetic Mice.The Journal of pharmacology and experimental therapeutics,356(2),324-32.
MLA Zhang, Eryun,et al."Notoginsenoside Ft1 Promotes Fibroblast Proliferation via PI3K/Akt/mTOR Signaling Pathway and Benefits Wound Healing in Genetically Diabetic Mice".The Journal of pharmacology and experimental therapeutics 356.2(2016):324-32.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace